Dupond et al. demonstrated the efficacy of RTX in a patient with multiple autoimmune conditions, including SPS, in which RTX led to remission and suppression of anti-amphiphysin antibodies but not anti-GAD [25]. This evidence concerns the gene AMPH and Autoimmunity.